Related Experiment Video
Updated: Aug 29, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
IRF4 as an Oncogenic Master Transcription Factor
Regina Wan Ju Wong1, Jolynn Zu Lin Ong1, Madelaine Skolastika Theardy1
1Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Interferon regulatory factor 4 (IRF4) is crucial in normal immunity and acts as an oncogene in lymphoid cancers. Understanding its regulatory circuits is key for developing targeted therapies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interferon regulatory factor 4 (IRF4) is a key transcription factor with distinct roles in immunity and cancer.
- IRF4 regulates normal lymphocyte development and immune responses through T-cell receptor and B-cell receptor pathways.
- Abnormal IRF4 expression is implicated as an oncogene in mature lymphoid neoplasms.
Purpose of the Study:
- To review the molecular functions of IRF4 in mature lymphoid neoplasms.
- To highlight the upstream and downstream pathways regulated by IRF4.
- To elucidate the transcriptional regulatory circuits involving IRF4 in cancer.
Main Methods:
- Literature review of studies on IRF4 function.
- Analysis of IRF4's role in normal immune cell signaling.
- Investigation of IRF4's oncogenic mechanisms in lymphoid malignancies.
Main Results:
- IRF4 acts as a master regulator, influencing immune cell-specific gene expression.
- IRF4 can induce oncogenes like MYC in malignant lymphoid cells.
- A regulatory circuit involving IRF4 and NF-κB maintains the oncogenic program.
Conclusions:
- IRF4 plays a dual role in normal immunity and lymphoid oncogenesis.
- Understanding IRF4's regulatory network is vital for cancer therapy.
- Targeting IRF4 pathways offers potential therapeutic strategies for lymphoid neoplasms.
Related Concept Videos
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

